Bafna Pharma spurts on launching RARICAP injection in domestic market

20 Nov 2013 Evaluate

Bafna Pharmaceuticals is currently trading at Rs. 26.45, up by 1 point or 3.93% from its previous closing of Rs. 25.45 on the BSE.

The scrip opened at Rs 26.00 and has touched a high and low of Rs 26.00 and Rs 25.65 respectively. So far 17000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 51.70 on 07-Jan-2013 and a 52 week low of Rs 17.90 on 29-Jul-2013.

Last one week high and low of the scrip stood at Rs 27.50 and Rs 24.00 respectively. The current market cap of the company is Rs 48.23 crore.

The promoters holding in the company stood at 30.87% while Non-Institutionsheld 69.13% of the stake.

Bafna Pharmaceuticals, a Chennai-based Pharma company, has launched RARICAP in injection form as RARICAP S in domestic market. This is another product in women wellness segment for Iron Deficiency Anaemia during Pregnancy and also for Anaemia in Chronic Kidney Disease.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

86.94 -1.06 (-1.20%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.